Torii Pharmaceutical Co Ltd represents values of excellence, integrity, and innovation. The company believes in delivering high-quality pharmaceutical products that improve the health and well-being of individuals. With a focus on research and development, Torii Pharmaceutical Co Ltd strives to provide innovative solutions and meet the changing needs of patients. The company's corporate philosophy emphasizes the importance of contributing to society through the development of safe and effective medications. By prioritizing patient-centric care, Torii Pharmaceutical Co Ltd aims to become a trusted partner in the global healthcare industry.

Torii Pharmaceutical Co Ltd is primarily present in Japan.

Since its establishment, Torii Pharmaceutical Co Ltd has reached several significant milestones. Notably, the company successfully launched its flagship product, Toubeauty®, an innovative skincare solution beloved by consumers worldwide. Torii Pharmaceutical Co Ltd also expanded its global presence by securing distribution agreements in key markets, further contributing to its growth and success. Additionally, the company has made strides in research and development, leading to the launch of groundbreaking pharmaceutical products that have positively impacted patients' lives. Overall, Torii Pharmaceutical Co Ltd continues to demonstrate its commitment to innovation, excellence, and improving the well-being of individuals through its remarkable achievements.

Torii Pharmaceutical Co Ltd is a renowned pharmaceutical company with a rich history and background. Founded in 1921, Torii Pharmaceutical has been providing innovative healthcare solutions for nearly a century. The company specializes in developing and manufacturing high-quality prescription drugs, over-the-counter medications, and healthcare products. With a strong emphasis on research and development, Torii Pharmaceutical has earned a reputation for its commitment to improving global health. Through strategic partnerships and collaborations, the company has expanded its global presence, delivering its products to diverse markets. Torii Pharmaceutical continues to strive for excellence, ensuring the well-being of individuals worldwide through cutting-edge pharmaceutical advancements.

The main competitors of Torii Pharmaceutical Co Ltd in the market include companies such as Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co., Ltd., and Shionogi & Co., Ltd.

Torii Pharmaceutical Co Ltd is primarily active in the pharmaceutical industry.

The business model of Torii Pharmaceutical Co Ltd revolves around the development, manufacturing, and sales of various pharmaceutical products. As a leading pharmaceutical company, Torii Pharmaceutical focuses on research and development to create innovative healthcare solutions. With a wide range of products spanning different therapeutic areas such as cardiovascular, respiratory, and central nervous system disorders, Torii Pharmaceutical aims to improve patient outcomes and enhance quality of life. Through strategic partnerships and collaborations, the company strives to expand its presence in both domestic and international markets, ensuring the delivery of high-quality and effective medications to patients worldwide.

Torii Pharmaceutical Co의 P/E 비율은 32.54입니다.

Torii Pharmaceutical Co의 P/S 비율은 2.6입니다.

Torii Pharmaceutical Co에 대한 AlleAktien 품질 점수는 6/10입니다.

예상되는 Torii Pharmaceutical Co 매출은 68.33 조. JPY입니다.

예상되는 Torii Pharmaceutical Co 이익은 5.47 조. JPY입니다.

Torii Pharmaceutical Co Ltd is a Japanese company specializing in the research, development, production, and marketing of pharmaceuticals. The company was founded in 1921 and is headquartered in Tokyo. The business model of Torii is based on developing and marketing innovative and effective drugs that contribute to improving the lives of patients. The company has a wide range of products in various therapy areas, such as cancer, cardiovascular diseases, metabolic disorders, immunology, and the nervous system. Torii operates in three main business areas: 1. Research and Development: Torii has an extensive research and development pipeline focused on novel drugs. The company invests heavily in the discovery and development of new pharmaceutical compounds and is constantly looking for promising technologies and therapies. 2. Manufacturing and Distribution: Torii has modern production facilities that meet the latest international standards to ensure that products are of high quality and safe. In addition, the company has an extensive distribution network in Japan and internationally to ensure that products can be delivered quickly and effectively to customers. 3. Brand Management: Torii markets and distributes its products under various brand names and is committed to raising awareness among the public and healthcare professionals. The company works closely with medical communities to maximize the effectiveness of its products and achieve broad market acceptance. Some of Torii's key products include: - Trelstar: A drug for the treatment of prostate cancer and endometriosis. - Edaravone: A neuroprotective drug for the treatment of amyotrophic lateral sclerosis (ALS). - Remitch: A drug for the treatment of sleep disorders. - Coniel: A drug for the treatment of hypertension. Torii also pursues a strategy of collaborating with other pharmaceutical companies to accelerate the development of new drugs and expand its global market presence. The company has already successfully formed partnerships with major international pharmaceutical companies such as Sanofi and Pfizer. Overall, Torii's business model aims to be a leading provider of pharmaceuticals that maintains a competitive position in the market through innovative technology, excellent product quality, and strong partnerships with other companies.

Torii Pharmaceutical Co은(는) 연간 번의 배당을 통해 100 JPY의 배당금을 지급합니다.

Torii Pharmaceutical Co의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Torii Pharmaceutical Co의 ISIN은 JP3635800000입니다.

Torii Pharmaceutical Co의 WKN은 887536입니다.

Torii Pharmaceutical Co의 티커는 4551.T입니다.

지난 12개월 동안 Torii Pharmaceutical Co은(는) 120 JPY 의 배당금을 지급했습니다. 이는 약 1.9 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Torii Pharmaceutical Co은(는) 121.83 JPY의 배당금을 지급할 것으로 예상됩니다.

Torii Pharmaceutical Co의 현재 배당 수익률은 1.9 %입니다.

Torii Pharmaceutical Co은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Torii Pharmaceutical Co은(는) 지난 23년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 121.83 JPY의 배당금이 예상됩니다. 이는 배당수익률 1.92 %에 해당합니다.

Torii Pharmaceutical Co은 '건강' 섹터에 속합니다.

Torii Pharmaceutical Co의 마지막 배당금을 60 JPY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2024년에 Torii Pharmaceutical Co는 120 JPY를 배당금으로 지급했습니다.

Torii Pharmaceutical Co의 배당금은 JPY에 지급됩니다.